Skip to main content
Signal8

Fry Simon Jeremy

SEC insider (Form 3/4/5 filer). CIK 0002046305. Director at CONDUIT PHARMACEUTICALS INC. (CDT). 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2025. Located in NAPLES, FL.

Companies Fry Simon Jeremy has filed insider reports for

  • CONDUIT PHARMACEUTICALS INC. (CDT): Director
Fry Simon Jeremy profile photo

Fry Simon Jeremy

CIK: 0002046305

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CONDUIT PHARMACEUTICALS INC. logo
CDT

CONDUIT PHARMACEUTICALS INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • CDT Equity Inc. logo
    CDT

    CDT Equity Inc.

    Aug 12, 2025
    Award
    Direct
    35K shares-
  • CDT Equity Inc. logo
    CDT

    CDT Equity Inc.

    Aug 5, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    15K shares-
  • CONDUIT PHARMACEUTICALS INC. logo
    CDT

    CONDUIT PHARMACEUTICALS INC.

    Mar 30, 2025
    Award
    Direct
    29.4K shares at avg. $0.89$26K
  • CONDUIT PHARMACEUTICALS INC. logo
    CDT

    CONDUIT PHARMACEUTICALS INC.

    Dec 18, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    420K shares at avg. $0.07-

1-4 of 4